News

As per the agreement, clinical trial sponsors based regionally and internationally will have access to clinical trial services throughout Asia, with a focus on early phase development. Parexel

AFN-1252, the clinical candidate from the company’s FASII program, is designed to selectively target the staphylococcal FabI enzyme. The Phase 2 trial is designed to confirm efficacy and

The products are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. The products are packaged in blister

Under the contract, Median will employ its LMS platform at all 65 investigator and independent review sites. The aim of the project is to reduce reading variability and

Under the collaboration agreement, Shire will receive exclusive world-wide rights to ZFP Therapeutics designed to target four genes which will be used to investigate curative therapies for hemophilia

The FDA has also agreed that all accelerated post-approval commitments for the indication have been met, which confirms the clinical benefit of adjuvant treatment with Gleevec. The approval

As per the agreement, Impax will even have non-exclusive rights to develop new products containing zolmitriptan and to exclusively commercialize these products in the US in connection with

PharmaSafe is designed to tackle the lack of control and visibility inherent in the involvement of too many parties. TNT controls the full supply chain, from packaging procurement

The financing is led by a consortium consisting Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners. Targovax CEO Hanne Mette D. Kristensen said the funding